Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer

NEW YORK, Oct. 14, 2021 -- (Healthcare Sales & Marketing Network) -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimm... Biopharmaceuticals, Personnel Immunic , immune modulator
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news